|
News Feeds |
|
Breast Cancer News From Medical News Today
|
Latest Breast Cancer News From Medical News Today.
|
-
Immutep Announces Positive Interim Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer
Immutep S.A. announced today interim results from its ongoing Phase I/II chemoimmunotherapy clinical trial in metastatic breast carcinoma. ImmuFact IMP321 was administered the day after weekly paclitaxel for six months. The interim results show a clinical response rate of 50 per cent compared to 25 per cent with paclitaxel alone. In addition, a robust immune response was observed in clinically-responding patients.
-
Cyclophilin B Is A Possible New Target For Treating Breast Cancer
Dr. Charles Clevenger and colleagues at Northwestern University have uncovered that cyclophilin B may contribute to progression in breast cancer. Their report can be found in the January 2009 issue of The American Journal of Pathology. The protein cyclophilin B affects cell division, motility, and death, all of which are altered in cancerous cells. To explore the role of cyclophilin B-mediated gene regulation in breast cancer, Dr.
-
UPCI Researcher Receives Grant To Study Breast Cancer Biomarkers
Susan G. Komen for the Cure has awarded Jean Johanna Latimer, Ph.D., assistant professor in the Molecular Genetics and Biochemistry Program at the University of Pittsburgh Cancer Institute (UPCI), a grant to develop biomarkers that will help identify which forms of a common, noninvasive cancer-ductal carcinoma in situ (DCIS)-will metastasize. The research, focusing in part on DCIS in African-American women, may eventually spare patients from unnecessary treatments.
-
Medicare Rebate For Breast MRI, Australia
A Medicare rebate for an MRI breast scan will be available to women under 50 at high risk of breast cancer and with no symptoms from 1 February 2009. Being at high risk of breast cancer can cause significant anxiety. These scans can help reduce unnecessary concern, and help pick up breast cancer early.
-
MRI Scans Funded For Younger Women At High Risk Of Breast Cancer, Australia
National Breast and Ovarian Cancer Centre welcomes the addition of two new items to the Medicare Benefits Schedule (MBS) for the use of Magnetic Resonance Imaging (MRI) in the surveillance and diagnosis of women under 50 years of age at high risk of developing breast cancer.
|
|